Long-acting progestogens

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 16, Issue 2, 2002, Pages 169-179

  Affandi, Biran ^a,b  

^a Division of Reproductive Health   (Indonesia)

^b UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

Long acting; Progestogens

Indexed keywords

DESOGESTREL; ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL VALERATE PLUS NORETHISTERONE ENANTATE; ETHINYLESTRADIOL; ETONOGESTREL; GESTAGEN; IBUPROFEN; INJECTABLE CONTRACEPTIVE AGENT; LEVONORGESTREL; NOMEGESTROL; NOMEGESTROL ACETATE; PLACEBO;

AMENORRHEA; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FAMILY PLANNING; HEALTH PROGRAM; HORMONAL CONTRACEPTION; HORMONE RELEASE; HUMAN; IMPLANT; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MICROCAPSULE; PILL; PREGNANCY; PRIORITY JOURNAL; REVIEW; VAGINA BLEEDING; VAGINA RING; CHEMICALLY INDUCED DISORDER; DELAYED RELEASE FORMULATION; DRUG IMPLANT; FEMALE; INJECTION; MENORRHAGIA;

DELAYED-ACTION PREPARATIONS; DRUG IMPLANTS; FEMALE; HUMANS; INJECTIONS; MENORRHAGIA; PROGESTINS;

EID: 0036527403     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1053/beog.2002.0268     Document Type: Article

References (21)

1. Folkman J & Long DM. The use of silicone rubber as a carrier for prolonged drug therapy. Journal of Surg Research 1964; 4: 139-142.
2. Dziuk J & Cook B. Passage of steroids through silicone rubber. Endocrinology 1966; 78: 208-211.
3. Segal SJ. Contraceptive subdermal implants. In Mishell DR Jr (ed.) Advances in Fertility Research pp 117-127. New York: Raven Press, 1982.
4. Odlind V. New delivery systems for hormonal contraception. Acta Obstetricia et Gynecologica Scandinavica Supplement 1986; 134: 15-20.
5. Population Reports, 1983. Long -acting progestins -promise and prospects, Series K, Number 2.
6. Population Reports. 1995. New Era for Injectables, Series K, Number 5.
7. WHO. A multicentered phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: I. Contraceptive efficacy and side effects. Contraception 1988; 37: 1-20.
8. Affandi B. Clinical, pharmacological and epidemiological studies on a levonorgestrel implant contraceptive, 1987. Dissertation. University of Indonesia.
9. Affandi B, Korver T, Paul Geurts TB & Coeling Bennink HJT. A phase II study with single implant contraceptive containing 3-ketodesogestrel. Medical Journal of Indonesia 1999; 8: 25-30.
10. Affandi B, Hoesni HM, Barus RP et al. A multicentred phase III study between Implanon and Norplant. Medical Journal of Indonesia 1999; 8: 49-55.
11. Lapido O & Cautinho EM. Contraceptive implants. Current Opinion in Obstetrics and Gynecology 1994; 6: 564-569.
12. Cullins VE. Injectable and implantable contraceptives. Current Opinion in Obstetrics and Gynecology 1992; 4: 536-543.
13. Cautinho EM, de Souza JC, Athaide C et al. Multicenter clinical trial on the efficacy and acceptability of Uniplant. Contraception 1996; 53: 121-125.
14. Population Reports. Hormonal contraception: new long acting methods, 1988. Series K, Number 3.
15. Diczfalusy E. New developments in oral, injectable and implantable contraceptives, vaginal rings and intrauterine device: A review. Contraception 1986; 33: 7-22.
16. Luukkainen T & Toivonen J. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Contraception 1995; 52: 269-276.
17. Menstrual bleeding patterns in Chinese women using the Norplant subdermal implant. Human Reproduction 1996; 11 (suppl 2): 14-9.
18. WHO. Clinical evaluation of the theurapeutic effectiveness of ethynil estradiol and oestrone sulphate on prolonged bleeding in women using DMPA. Human Reproduction 1996; 11 (suppl 2): 1-13.
19. Fraser IS. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives. Contraception 1983; 28: 385-397.
20. Diaz S & Corxatto HB. Clinical assessment of treatments for prolonged bleeding in users of Norplant implant. Contraception 1990; 42: 97-109.
21. Archer DF, Philput A & Weber ME. Management of irregular bleeding and spotting associated with Norplant. Human Reproduction 1996; 11 (suppl 2): 24-30.